Ursprung des Netzwerks ersten Grades von Chris Miller
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Altacor Ltd.
Altacor Ltd. Pharmaceuticals: MajorHealth Technology Altacor Ltd. operates as a specialist ophthalmology company develops and markets a portfolio of products in the fields of dry eye, glaucoma and ocular infection. The company was founded by Francesca Elizabeth Crawford and David Francis Alcraft in 2007 and is headquartered in Theale, the United Kingdom.
3
| Private Company | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Chris Miller
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CARA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
SEVER Life Sciences BV | Director/Board Member | ||
POLYPEPTIDE GROUP AG | Biotechnology | Director/Board Member | |
C&P Investors Ltd. | Chief Executive Officer | ||
Draupnir Holding BV
Draupnir Holding BV Miscellaneous Commercial ServicesCommercial Services Draupnir Holding BV provides organizational, business, and management consulting services. The private company is based in Hoofddorp, Netherlands. | Miscellaneous Commercial Services | Director/Board Member | |
Erasmus University Rotterdam | College/University | Graduate Degree | |
PolyPeptide Laboratories Holding (PPL) AB
PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance PolyPeptide Laboratories Holding (PPL) AB manufactures commercial therapeutic peptides. The firm offers polypeptide, custom peptide synthesis, peptide synthesis, and generic peptide. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Financial Conglomerates | Director/Board Member | |
Svar Life Science AB
Svar Life Science AB Miscellaneous Commercial ServicesCommercial Services Svar Life Science AB is a Swedish company that provides GMP and non-GMP bioassay services for drug development. The private company is based in Malmö, Sweden. The company specializes in using activity biomarkers to determine if deficiencies, overactivation, or dysregulation in the complement system are causing or contributing to a person's disease or condition. The company offers method development, qualification, validation, and method improvements throughout the drug development lifecycle. Anne Thjømøe has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
AMARIN CORPORATION PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Haydn Holding AB | Director/Board Member | ||
Ferring Foundation BV
Ferring Foundation BV Financial ConglomeratesFinance Part of Ferring Pharmaceuticals BV/NL/, Ferring Foundation BV functions as an investment holding and Dutch management company. The company is based in Hoofddorp, Netherlands. | Financial Conglomerates | Director/Board Member | |
FinVector Oy
FinVector Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Ventures, FinVector Oy is a Finnish biopharmaceutical company that specializes in manufacturing viral-based gene therapy products. The company is based in Kuopio, Finland, and has extensive experience in cgmp manufacturing. FinVector employs hundreds of highly qualified professionals from over 40 different countries and works on cutting-edge biopharmaceuticals. It has invested in building state-of-the-art gmp facilities for viral vector platforms. The company was founded in 1993 by Seppo Ylä-Herttuala, and the CEO is Giuseppe Carloni. | Pharmaceuticals: Major | Director/Board Member | |
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director of Finance/CFO | |
Unisource NV
Unisource NV Specialty TelecommunicationsCommunications Unisource NV provides telecommunications services. The company is a holding company that owns and operates subsidiaries including Deutsche Telekom, AT&T-Unisource Communications Services, and Unisource Carrier Services. It was founded in 1992 and is headquartered in Hoofddorp, the Netherlands. | Specialty Telecommunications | Comptroller/Controller/Auditor | |
Arthur Andersen Accountants
Arthur Andersen Accountants Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Arthur Andersen Accountants is a Dutch company that provides accounting services. The company is based in Rotterdam, Netherlands. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Somanautix Ltd.
Somanautix Ltd. BiotechnologyHealth Technology Somanautix Ltd. is a British company that develops viruses to penetrate cells. The private company is based in Cambridge, UK and was founded in 2017. | Biotechnology | Director/Board Member | |
ADC Products (UK) Ltd.
ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services ADC Products (UK) Ltd. operates as a clinical stage biotechnology company. It develops pyrrolobenzodiazepines for antibody-drug conjugation. The company was founded in November 2000 and is headquartered in Reading, the United Kingdom. | Medical/Nursing Services | Corporate Officer/Principal | |
Arquer Diagnostics Ltd.
Arquer Diagnostics Ltd. Medical/Nursing ServicesHealth Services Arquer Diagnostics Ltd. develops proprietary diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. Its develops non-invasive, urine-based ELISA and Point-of Care tests meet the increased demand for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes. The firm will commercialise ELISA and point-of-care urine tests for prostate and bladder cancer for use in the urology clinic, hospital lab and the GP’s surgery. The company was founded by David Nicholas Miller-Jones and William Dawson in 2007 and is headquartered in Sunderland, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Esperante BV
Esperante BV Investment ManagersFinance Esperante BV (Esperante) is a Dutch based venture capital firm which was founded by Dean Slagel in 2004. Esperante is a seed investor which invests in emerging biotechnology companies engaged in the development of novel therapeutics in areas of major unmet medical need. The firm has a portfolio of investments across France, the UK and the US. The firm provides investee companies with extended management resources, particularly in business development, as a complement to their financial contribution. They also conduct scientific and intellectual property evaluations using confidential life science industry consultants. | Investment Managers | Chief Executive Officer | |
Ecole Nationale des Ponts et Chaussées | College/University | Masters Business Admin | |
Canbex Therapeutics Ltd.
Canbex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Canbex Therapeutics Ltd. engages in the development of novel peripherally-acting cannabinoid agonists and mimetics for the treatment of multiple sclerosis spasticity and pain. Its lead drug candidate, VSN 16, has been established as a potent, stable and orally-available agonist of GPR-55 with a clear anti-spasticity effect in a validated preclinical model. The company was founded by David Baker, Gavin Giovannoni, Cristina Visintin, Gareth Pryce and David Lawrence Selwood in 2005 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Esperante AB | Chief Executive Officer | ||
Sirus Pharmaceuticals Ltd
Sirus Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Sosei Group Corp., Sirus Pharmaceuticals Ltd is a British pharmaceutical company that manufactures drugs targeting the nervous system. The company is based in Cambridge, UK. The company was founded by Fran Crawford. Sirus Pharmaceuticals was acquired by Sosei R&D Ltd., a subsidiary of Sosei Group Corp. from Drumz Plc on March 15, 2004. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ferring Pharmaceuticals Ltd.
Ferring Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals Ltd. manufactures and produces pharmaceutical products. It offers Zomacton (somatropin) for that treatment of growth failure in children and for girl’s diagnosed with Turners syndrome; GONAPEPTYL (triptorelin), a GnRH agonist that is used for the treatment of children with central precocious puberty; Testim (testosterone gel), a hydroalcoholic topical gel; and PENTASA (mesalazine), which is used for the treatment of inflammatory bowel diseases. The company was founded in 1975 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oxford Cancer Biomarkers Ltd.
Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom. | Hospital/Nursing Management | Director/Board Member | |
Haemostatix Ltd.
Haemostatix Ltd. Pharmaceuticals: MajorHealth Technology Haemostatix Ltd. designs and develops solutions for haemostasis and thrombosis. Its products include Rapid and effective haemostatic action which is new class of topical coagulant or haemostat that is applied directly to a wound during surgery to control bleeding, and ready-to-use formulations, blood-free ingredients and a new class with a unique mode of action. The company was founded by Sarah Middleton and Alison Goodall in 2003 and is headquartered in Nottingham, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Esperante Ltd.
Esperante Ltd. Investment ManagersFinance Esperante Ltd. operates as a venture investment company controlled by C&P Group Holdings. The company was founded on April 29, 1986 and is headquartered in Maidenhead, the United Kingdom. | Investment Managers | Chief Executive Officer | |
Esperante Investments S. r.l. | Chief Executive Officer |
Statistik
International
Vereinigtes Königreich | 13 |
Niederlande | 8 |
Schweden | 5 |
Frankreich | 5 |
Schweiz | 3 |
Sektoral
Health Technology | 17 |
Finance | 7 |
Commercial Services | 4 |
Health Services | 4 |
Consumer Services | 3 |
Operativ
Director/Board Member | 24 |
Chief Executive Officer | 7 |
Corporate Officer/Principal | 5 |
Comptroller/Controller/Auditor | 3 |
Independent Dir/Board Member | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Dean Marc Slagel | 18 |
Erik Schropp | 16 |
Francesca Elizabeth Crawford | 5 |
- Börse
- Insiders
- Chris Miller
- Unternehmensverbindungen